Patent details

EP3496743 Title: COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ARGININE DEPLETION AND IMMUNO ONCOLOGY AGENTS

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3496743
WO Application Number:
US2017050816
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP17840420.8
WO Publication Number:
WO2018032020
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
08/09/2017
Grant date:
09/02/2022
EP Publication Date:
19/06/2019
WO Publication Date:
15/02/2018
Claims Translations Received Date:
Claims Translation B1 Received Date:
30/03/2022
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
09/02/2022
EP B1 Publication Date:
09/02/2022
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
07/09/2037
Lapsed By Expiration Date:
Patent Validated Date:
13/04/2022
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
26/08/2024
 
 

 

Name:
Immedica Pharma AB
Address:
Solnavägen 3H, 113 63, Stockholm, Sweden (SE)

Historical Applicant/holder

From:
09/02/2022
To:
26/08/2024

 

Name:
AERase, Inc.
Address:
901 S. Mopac Expressway Barton Oaks Plaza One, Suite 250, Austin, TX 78746, United States of America (US)

Agent

Name:
drs. C.M.A. Quintelier
From:
12/04/2022
Address:
KIRKPATRICK 32 Avenue Wolfers, B-1310, La Hulpe, Belgium (BE)
To:

Inventor

1

Name:
LOWE, David
Address:
Austin, TX 78735, United States of America (US)

2

Name:
ROWLINSON, Scott, W.
Address:
Austin, TX 78746, United States of America (US)

3

Name:
ALTERS, Susan
Address:
Palo Alto, CA 94306, United States of America (US)

4

Name:
AGNELLO, Giulia
Address:
Austin, TX 78751-5023, United States of America (US)

Priority

1

Priority Patent Number:
201762524286 P
Priority Date:
23/06/2017
Priority Country:
United States of America (US)

2

Priority Patent Number:
201662372092 P
Priority Date:
08/08/2016
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 38/50; A61K 39/00; C07K 16/28; C12N 9/78; A61P 35/00;

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
36/24
Publication date:
04/09/2024
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
EP3
Journal edition number:
15/22
Publication date:
13/04/2022
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:
EP2
Journal edition number:
06/22
Publication date:
09/02/2022
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
202206
Publication date:
09/02/2022
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC202401550A
Date Registered:
26/08/2024
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
dr. R.C. van Duijvenbode c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Immedica Pharma AB
Address:
Solnavägen 3H, 113 63, Stockholm, Sweden (SE)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
30/09/2026
Annual Fee Number:
10
Annual Fee Amount:
400 Euro
Last Annual Payment Date:
16/06/2025
Last Annual Fee Paid Number:
9
Last Annual Fee Paid Amount:
340 Euro
Payer:
Zacco Sweden AB Patent Department
Filing date Document type Document Description Number of pages File Type
12/04/2022 Outgoing Correspondence Letter no formal defects 1 PDF /8/5/1/6/6/0800766158/docs/ep17840420.8_0_473703l271.pdf
30/03/2022 Claims First filed claims 3 PDF /8/5/1/6/6/0800766158/docs/ep17840420.8_1_claims20220330124503952.pdf